J.W. Cole Advisors Inc. Purchases Shares of 1,243 Axon Enterprise, Inc. (NASDAQ:AXON)

J.W. Cole Advisors Inc. bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the second quarter, HoldingsChannel reports. The institutional investor bought 1,243 shares of the biotechnology company’s stock, valued at approximately $366,000.

Other institutional investors have also made changes to their positions in the company. Avantax Advisory Services Inc. lifted its position in shares of Axon Enterprise by 0.8% during the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after purchasing an additional 40 shares in the last quarter. GSA Capital Partners LLP acquired a new position in shares of Axon Enterprise during the first quarter worth $931,000. Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Axon Enterprise by 14.8% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 170,376 shares of the biotechnology company’s stock worth $53,307,000 after buying an additional 22,013 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Axon Enterprise by 21.7% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 9,153 shares of the biotechnology company’s stock worth $2,693,000 after buying an additional 1,634 shares during the last quarter. Finally, Cim LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth $1,409,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Axon Enterprise news, CEO Patrick W. Smith sold 70,000 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $362.21, for a total value of $25,354,700.00. Following the completion of the sale, the chief executive officer now directly owns 2,945,366 shares of the company’s stock, valued at approximately $1,066,841,018.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The disclosure for this sale can be found here. Insiders sold 317,981 shares of company stock valued at $115,662,734 over the last 90 days. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 0.1 %

Axon Enterprise stock opened at $383.01 on Thursday. The company has a 50-day simple moving average of $342.26 and a 200-day simple moving average of $315.72. The firm has a market capitalization of $28.90 billion, a P/E ratio of 111.99, a P/E/G ratio of 10.30 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise, Inc. has a one year low of $189.12 and a one year high of $387.61.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company’s quarterly revenue was up 34.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.80 earnings per share. As a group, equities analysts expect that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on AXON shares. Robert W. Baird lifted their price target on shares of Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 10th. Needham & Company LLC restated a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Northland Securities lifted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. JMP Securities lifted their price target on shares of Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Finally, Barclays boosted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $365.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.